Isodixanol Injection, containing Iodixanol at a concentration of 625 mg/ml, is a non-ionic, iso-osmolar radiographic contrast agent used primarily for intravascular administration during diagnostic imaging procedures. It enhances the contrast of vascular structures and organs in X-ray-based imaging modalities such as computed tomography (CT), angiography, and urography. Due to its iso-osmolar properties, Isodixanol Injection minimizes the risk of osmotic-related adverse effects compared to hyperosmolar contrast media, making it suitable for patients with compromised renal function or those at risk of contrast-induced nephropathy. The agent is rapidly distributed in the intravascular compartment and eliminated primarily via renal excretion. Isodixanol exhibits a favorable safety profile, with adverse reactions typically mild and transient, including nausea, headache, or injection site discomfort. However, caution is advised in patients with known hypersensitivity to iodinated contrast media, severe cardiac or renal impairment, or thyroid disorders. Proper hydration before and after administration is recommended to facilitate renal clearance. Dosage and administration should be tailored to the specific imaging procedure and patient characteristics, adhering to established guidelines to optimize diagnostic efficacy while minimizing potential risks.